1,410 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Tomtom NV 2016 Q2 - Results - Earnings Call Slides http://seekingalpha.com/article/3989367-tomtom-nv-2016-q2-results-earnings-call-slides?source=feed_all_articles Jul 19, 2016 - The following slide deck was published by Tomtom NV in conjunction with their 2016 Q2 earnings call.
Tomtom NV reports Q2 results http://seekingalpha.com/news/3193873-tomtom-nv-reports-q2-results?source=feed_news_all Jul 19, 2016 - Tomtom NV (TMOAF): Q2 EPS of €0.10 vs. €0.05 in 2Q15. Revenue of €265M (flat Y/Y) Press Release
Novartis (NVS) Beats Earnings & Sales in Q2 http://www.zacks.com/stock/news/223885/novartis-nvs-beats-earnings-sales-in-q2?cid=CS-ZC-FT-223885 Jul 19, 2016 - Novartis beat on earnings in the second quarter of 2016.
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG http://www.zacks.com/stock/news/223699/3-drug-stocks-to-report-earnings-on-jul-19-jnj-nvs-neog?cid=CS-ZC-FT-223699 Jul 18, 2016 - Three drug stocks including industry bellwether Johnson & Johnson (JNJ) will report results on Jul 19.
Novartis (NVS) Likely to Beat Q2 Earnings: Stock to Gain? http://www.zacks.com/stock/news/223654/novartis-nvs-likely-to-beat-q2-earnings-stock-to-gain?cid=CS-ZC-FT-223654 Jul 15, 2016 - Novartis AG (NVS) is scheduled to report second-quarter 2016 results on Jul 19.
Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/223578/biogen-biib-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-223578 Jul 15, 2016 - Will Tecfidera scrips and sales recover enough to boost Biogen's (BIIB) performance in the second quarter?
J&J (JNJ) May Beat Q2 Earnings: Will the Stock Gain? http://www.zacks.com/stock/news/223564/jj-jnj-may-beat-q2-earnings-will-the-stock-gain?cid=CS-ZC-FT-223564 Jul 15, 2016 - J&J (JNJ) has a pretty good track record and could beat estimates in the second quarter given the Zacks Rank #2 and +1.80% ESP.
Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation http://www.zacks.com/stock/news/223501/novartis-enbrel-biosimilar-gets-fda-panel-recommendation?cid=CS-ZC-FT-223501 Jul 14, 2016 - Novartis AG (NVS) announced that the FDA's Arthritis Advisory Committee has recommended an approval of the company's proposed biosimilar of Amgen's (AMGN) blockbuster drug, Enbrel (etanercept).
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan http://www.zacks.com/stock/news/223470/amgen-and-daiichi-sankyo-team-up-for-biosimilars-in-japan?cid=CS-ZC-FT-223470 Jul 14, 2016 - Amgen (AMGN) inked an exclusive agreement with Daiichi Sankyo for the commercialization of nine biosimilars in Japan.
Wright Medical Group NV (WMGI) Robert J. Palmisano on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3971582-wright-medical-group-nv-wmgi-robert-j-palmisano-q1-2016-results-earnings-call-transcript?source=feed_all_articles May 05, 2016 - Wright Medical Group NV (NASDAQ:WMGI)Q1 2016 Earnings CallMay 04, 2016 4:30 pm ETExecutivesJulie D. Tracy - Chief Communications Officer & Senior VP, Wright Medical Group, Inc.Robert J. Palmisano - Pr
<<<Page 138>